Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04205656 · ClinicalTrials.gov registry record · Phase 1
Prospective Evaluation of PRP and BMC Treatment to Accelerate Healing After ACL Reconstruction
A Phase 1 study of Osteoarthritis, Knee, sponsored by Steadman Philippon Research Institute.
- Active
- Registry status
- Phase 1
- Development phase
- 45
- Enrollment target
- 1
- Study location
NCT04205656 is a Phase 1 study of Osteoarthritis, Knee that is active but no longer recruiting, run by Steadman Philippon Research Institute. The registered enrollment target is 45 participants, below the 579-participant average among 91 other Osteoarthritis, Knee trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04205656, a Phase 1 study of Osteoarthritis, Knee, is active but no longer recruiting, sponsored by Steadman Philippon Research Institute.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 1
- Development phase
- 45 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a prospective, randomized, placebo-controlled trial to evaluate potential beneficial effects of leukocyte-poor platelet rich plasma and bone marrow concentrate on the healing and health of critical joint tissues in the knee following anterior cruciate ligament (ACL) reconstruction. Bone marrow contains stem cells which can change into cells of various different tissue types, while platelet rich plasma contains growth factors. This trial will compare the two procedures against placebo.
Conditions Studied
Interventions
- BIOLOGICAL Leukocyte-Poor Platelet Rich Plasma (LP-PRP)
- BIOLOGICAL Bone Marrow Concentrate (BMC)
- OTHER Control group (Placebo)
Study Locations (1)
Colorado
- 181 West Meadow Drive, Suite 1000 - Vail
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2020-01-02 |
| Est. Completion | 2024-09 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04205656
The ClinicalTrials.gov registry entry for NCT04205656 describes a study currently listed as active not recruiting, categorized as Phase 1. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 579-participant average among 91 other Osteoarthritis, Knee trials with a reported enrollment target (92% lower). The listed sponsor is Steadman Philippon Research Institute, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Osteoarthritis, Knee appearing as the primary indexed condition, and to 3 interventions - of which Leukocyte-Poor Platelet Rich Plasma (LP-PRP) is the first listed.
NCT04205656 reports 1 study location spanning 1 distinct geographic area - top geographies include Colorado.
Frequently Asked Questions
What is clinical trial NCT04205656 about?
NCT04205656 is a clinical study titled "Prospective Evaluation of PRP and BMC Treatment to Accelerate Healing After ACL Reconstruction". This is a prospective, randomized, placebo-controlled trial to evaluate potential beneficial effects of leukocyte-poor platelet rich plasma and bone marrow concentrate on the healing and health of critical joint tissues in the knee following anterior cruciate ligament (ACL) reconstruction. Bone marr...
What is the current status of trial NCT04205656?
This trial is currently active not recruiting. It is a Phase 1 study. The enrollment target is 45 participants. The study started on 2020-01-02. Estimated completion is 2024-09.
What conditions does trial NCT04205656 study?
This clinical trial studies the following conditions: Osteoarthritis, Knee.
What interventions are being tested in trial NCT04205656?
The interventions under investigation include: Leukocyte-Poor Platelet Rich Plasma (LP-PRP) (BIOLOGICAL), Bone Marrow Concentrate (BMC) (BIOLOGICAL), Control group (Placebo) (OTHER).
Who is sponsoring clinical trial NCT04205656?
This trial is sponsored by Steadman Philippon Research Institute, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04205656 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Osteoarthritis, Knee
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Hip Flexion Feedback System for Exercise Monitoring in Individuals With Osteoarthritis and Obesity
RECRUITING · Phase 1
-
CBD for Knee Osteoarthritis
RECRUITING · Phase 1
-
Oral Steroid Taper After Total Knee Arthroplasty
RECRUITING · Phase 1
-
Safety and Pharmacodynamics of GNSC-001 Intra-articular Injection for Knee Osteoarthritis
ACTIVE NOT RECRUITING · Phase 1
-
Use of Senolytic and Anti-Fibrotic Agents to Improve the Beneficial Effect of Bone Marrow Stem Cells for Osteoarthritis
ACTIVE NOT RECRUITING · Phase 1
-
Study to Evaluate the Safety and Tolerability of FX201 in Patients with Osteoarthritis of the Knee
ACTIVE NOT RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.